Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$57.48
neg -0.86
-1.47%
Today's Range: 57.48 - 58.31 | MRK Avg Daily Volume: 11,300,500
Last Update: 03/31/15 - 4:02 PM EDT
Volume: 10,421,982
YTD Performance: 2.73%
Open: $58.19
Previous Close: $58.34
52 Week Range: $52.49 - $63.62
Oustanding Shares: 2,838,192,933
Market Cap: 163,905,641,881
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 7 7 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.08 2.08 2.00 2.00
Latest Dividend: 0.45
Latest Dividend Yield: 3.12%
Dividend Ex-Date: 03/12/15
Price Earnings Ratio: 14.19
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
14.19 14.20 27.35
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.20% 4.22% 51.93%
GROWTH 12 Mo 3 Yr CAGR
Revenue -4.10 -0.12 -0.04
Net Income 164.20 0.87 0.23
EPS 176.90 1.02 0.26
Earnings for MRK:
EBITDA 13.37B
Revenue 42.24B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $0.77 $0.80 $3.40 $3.82
Number of Analysts 7 7 10 10
High Estimate $0.82 $0.86 $3.48 $4.10
Low Estimate $0.73 $0.75 $3.28 $3.45
Prior Year $0.88 $0.85 $3.49 $3.40
Growth Rate (Year over Year) -12.18% -5.71% -2.55% 12.44%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Combined Heinz-Kraft heads a long second-quarter list.
Market will be closed when employment report comes out.
We won't get a real bottom until they happen.
Good buys kept getting overlooked.
Update
Mar 11, 2015 | 7:52 AM EDT
Barclays Healthcare Conference

The Fibocall: Merck Real Money Pro($)

The shares are inside the bounce zone.
Update
Mar 03, 2015 | 5:09 AM EST
Cowen Health Care Conference (Day 2 of 3) - 03/02/15 - 03/04/15 Boston, MA
Bearish
Feb 05, 2015 | 8:00 AM EST
MRK estimates were cut through 2016, BMO Capital said. Company is facing significant growth headwinds. Market Perform rating and new $6...
Use the overall weakness to pick up the America First stocks.
Low P/E multiples just aren't any protection.

Columnist Conversations

The cluster of high wick candles that formed in February and early this month may have been a tell, but Linded...
When the tide goes out is when we will find out how ugly things really are. The waters are getting more turbul...
Market ends the month and the quarter on a down note. Indices are largely flat for 2015, in the weakest openi...
Micron is holding a key support zone ahead of Thursday afternoon's Q2 earnings report. Today the stock i...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.